Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1999, p. 3872-3878, Vol. 37, No. 12
Department of Bacteriology,
Received 25 November 1998/Returned for modification 12 January
1999/Accepted 23 July 1999
Two hundred twenty-nine consecutive isolates of Mycobacterium
tuberculosis complex from patients with pulmonary tuberculosis in
Guinea-Bissau, which is located in West Africa, were analyzed for
clonal origin by biochemical typing and DNA fingerprinting. By using
four biochemical tests (resistance to thiophene-2-carboxylic acid
hydrazide, niacin production, nitrate reductase test, and pyrazinamidase test), the isolates could be assigned to five different biovars. The characteristics of four strains conformed fully with the
biochemical criteria for M. bovis, while those of 85 isolates agreed with the biochemical criteria for M. tuberculosis. The remaining 140 isolates could be allocated into
one of three biovars (biovars 2 to 4) representing a spectrum between
the classical bovine (biovar 1) and human (biovar 5) tubercle bacilli.
By using two genotyping methods, restriction fragment length
polymorphism analysis with IS6110 (IS6110 RFLP
analysis) and spoligotyping, the isolates could be separated into three
groups (groups A to C) of the M. tuberculosis complex.
Group A (n = 95), which contained the majority of
classical human M. tuberculosis isolates, had large numbers
of copies of IS6110 elements (mean number of copies, 9) and
a distinctive spoligotyping pattern that lacked spacers 33 to 36. Isolates of the major group, group B (n = 119), had fewer IS6110 copies (mean copy number, 5) and a
spoligotyping pattern that lacked spacers 7 to 9 and 39 and mainly
comprised isolates of biovars 1 to 4. Group C isolates
(n = 15) had one to three IS6110 copies,
had a spoligotyping pattern that lacked spacers 29 to 34, and
represented biovar 3 to 5 isolates. Four isolates whose biochemical
characteristics conformed with those of M. bovis clustered
with the group B isolates and had spoligotype patterns that differed
from those previously reported for M. bovis, in that they
possessed spacers 40 to 43. Interestingly, isolates of group B and, to
a certain extent, also isolates of group C showed a high degree of
variability in biochemical traits, despite genotypic identity in terms
of IS6110 RFLP and spoligotype patterns. We hypothesize
that isolates of groups B and C have their evolutionary origin in West
Africa, while group A isolates are of European descent.
Tuberculosis (TB) is globally a
major cause of morbidity and mortality, with most cases occurring in
developing countries (20, 27). According to the World Health
Organization, one-third of the world's population is infected with
organisms of the Mycobacterium tuberculosis complex, with
about 10 million cases of active TB disease reported each year, leading
to 3 million deaths annually (6). An increased morbidity and
mortality in TB patients is associated with the ongoing human
immunodeficiency virus (HIV) pandemic. Guinea-Bissau has one of the
highest incidences of TB in the world, with the annual incidence
estimated to be 150/100,000 population. The current epidemic of HIV
type 2 (HIV-2) infections (21) and the now emerging HIV-1
epidemic in Guinea-Bissau may contribute to a still higher incidence of TB.
It has long been observed that West African M. tuberculosis
strains are biochemically more heterogeneous than European strains. Prat and colleagues (23) speculate that the biochemical
heterogeneity observed among African strains represents a continuous
spectrum linking the classical human and bovine variants of M. tuberculosis. David and coworkers (4), on the other
hand, found that M. africanum strains tended to form two
clusters on the basis of biochemical traits: one related to the human
type and one related to the bovine type of M. tuberculosis
complex. In a previous epidemiological study (16) we
subtyped 56 M. tuberculosis complex strains isolated from
patients with pulmonary TB in Guinea-Bissau into five biovars. On the
basis of our biochemical methods, we identified five biovars representing a spectrum of strains ranging from classical human M. tuberculosis strains to classical M. bovis
strains. Two biovars corresponded to the so-called African I variant,
and one biovar corresponded to the African II variant described by
Collins et al. (2).
To study the population structure of M. tuberculosis complex
isolates in Guinea-Bissau, we have investigated 229 M. tuberculosis isolates by the same biochemical methods used in our
previous study, as well as by genetic molecular fingerprinting, using
the insertion sequence IS6110 and the spacer regions within
the direct repeat (DR) locus of M. tuberculosis as targets.
The insertion sequence IS6110 belongs to the larger
IS3 family of insertion elements and is regarded to be
specific for the M. tuberculosis complex. The DR locus of
the M. tuberculosis complex genome contains multiple, highly
conserved 36-bp DRs separated by 35- to 41-bp variable spacer sequences
(9). On the basis of the results presented here, we
hypothesize that the majority of M. tuberculosis complex
isolates belong to a unique family of strains that originated and
evolved in West Africa.
Patients.
Approximately 900 consecutive patients with
suspected TB (and without known previous treatment for TB) were
examined from 1989 to 1994 as part of an epidemiological study of TB in
Guinea-Bissau (5, 15, 16, 19, 21). The ages and sexes of the
patients were recorded, and during 1992 and 1993, testing for HIV-1 and HIV-2 was performed as described previously (21). Patients
with positive cultures for M. tuberculosis complex
(n = 229) were included in this study.
M. tuberculosis complex isolates.
Sputum samples
were collected from all patients by a registered nurse and were
transported at 4°C to the laboratory. Acid-fast microscopy was
performed after staining by the Ziehl-Neelsen method. Before culture,
the sputum samples were decontaminated of nonmycobacterial microorganisms by the sodium lauryl sulfate method (10). A
0.5-ml aliquot of the homogenized specimen was then inoculated into
both conventional Löwenstein-Jensen egg medium (LJ) and LJ
supplemented with 0.6% pyruvate. The samples were incubated at 37°C
and were examined weekly for 7 weeks. Growth of mycobacteria was
confirmed by microscopic observation of acid-fast bacilli. In total,
229 strains of M. tuberculosis complex were isolated from
these patients. Fifty-six of these isolates were also part of a
previous study (16).
Characterization of isolates.
All isolates were further
characterized by macroscopic and microscopic appearance and growth
characteristics and were biochemically characterized as described
earlier (15, 18). Resistance to thiophene-2-carboxylic acid
hydrazide (TCH; 5 mg/liter) was determined by radiometric respirometry
(BACTEC system; Becton Dickinson, Sparks, Md.). Detection of niacin was
performed as described by Wayne (33), and the nitrate
reductase test and pyrazinamidase test were performed as described by
Kent and Kubica (18). Testing for susceptibility to the
drugs ethambutol, isoniazid, rifampin, and streptomycin was performed
by using the BACTEC system (15, 25). All isolates were also
tested with a nucleic acid probe specific for M. tuberculosis complex (Accuprobe system; Gen-Probe, San Diego,
Calif.).
IS6110 RFLP analyses.
A standardized method for
restriction fragment length polymorphism (RFLP) analysis with
IS6110 (IS6110 RFLP analysis) (29) was
used. Genomic M. tuberculosis DNA was extracted and digested with the restriction endonuclease PvuII, and Southern
blotting was performed after separation of the restriction fragments by electrophoresis. Hybridization was performed with a 245-bp PCR fragment
of the IS6110 sequence as a probe. The probe was
nonradioactively labelled with peroxidase and was subsequently
visualized by the use of an enhanced chemiluminescence kit (Amersham
International plc, Little Chalfont, United Kingdom).
Spoligotyping.
Spoligotyping relied on the amplification of
the polymorphic DR region (17) to obtain hybridizations
patterns of the amplified DNA by using multiple synthetic spacer
oligonucleotides which are covalently bound to a membrane (Isogen
Bioscience BV, Maarssen, The Netherlands).
M. tuberculosis complex isolates from 229 consecutive
patients with bacteriologically verified pulmonary TB were
characterized by biochemical tests, drug susceptibility testing,
IS6110 RFLP analysis, and spoligotyping.
Patient characteristics.
All except eight of the patients were
native to Guinea-Bissau. The eight patients from other countries came
from the neighboring West African countries of Guinea Conakry (five
patients), Senegal (two patients), and The Gambia (one patient). The
mean age of the patients was 39 years, with 58% being male (mean age,
41 years) and 42% being female (mean age, 37 years). Of the 229 patients, 154 were tested for HIV; 118 were HIV negative, 3 (1.9%)
were HIV-1 positive, 29 (18.8%) were HIV-2 positive, and 4 (2.6%)
were infected with both HIV-1 and HIV-2.
Characterization of isolates.
All isolates had typical macro-
and microscopic appearances upon acid-fast staining and were positive
by the M. tuberculosis complex-specific nucleic acid probe
assay. Fifteen isolates were resistant to any of four major
antituberculous drugs (six were resistant to streptomycin, eight were
resistant to isoniazid, and one was resistant to streptomycin and
isoniazid) (5). By using four biochemical tests (resistance
to TCH, niacin production, nitrate reductase test, and pyrazinamidase
test) the M. tuberculosis complex isolates could be assigned
to five different biovars (Table 1). The
characteristics of 4 strains conformed fully with the biochemical
criteria for M. bovis (sensitivity to TCH and negativity by
the other tests), while those of 85 isolates agreed with the biochemical criteria for M. tuberculosis (resistance to TCH
and positivity by the other tests). The remaining 140 isolates could be
allocated to one of three biovars representing a spectrum between the
classical human and bovine tubercle bacilli (Table 1).
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evolution and Clonal Traits of Mycobacterium
tuberculosis Complex in Guinea-Bissau
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Biovars of 229 isolates of M. tuberculosis complex
Characteristics of IS6110 RFLP patterns. The 229 M. tuberculosis complex isolates were analyzed by an RFLP assay with the insertion sequence IS6110 as the target. All isolates had RFLP patterns that contained one or more bands that hybridized with the IS6110 probe (Fig. 1), with the number of IS6110 insertions ranging between 1 and 17 copies. The Dice coefficient of similarity for all pairwise comparisons of the isolates in the whole collection ranged from 0 to 100%; 147 (64%) of the isolates belonged to clusters of strains with identical and/or closely related banding patterns (defined as a coefficient of similarity of >90%), while 36% had less similar patterns. Altogether, 119 distinct banding patterns were found; 33 patterns were shared by two or more isolates, constituting 37 different clusters (defined as at least two isolates with identical RFLP patterns). The different clusters each comprised 2 to 33 isolates (Fig. 1). The largest cluster comprised isolates with a four-band pattern (Fig. 1). Twelve isolates, which showed only a single band, could be separated into two groups of four and eight isolates, respectively, on the basis of slightly different band migration patterns.
|
Spoligotyping.
Spoligotyping was performed with all 229 isolates. We identified 73 different spoligotype patterns, and these
were used to classify the isolates into three main groups, designated
sptA, sptB, and sptC (Table 2). The sptA
group, consisting of 88 isolates, lacked spacer 33 to 36, with 38 of
these isolates also lacking spacer 21 to 24. The largest group (117 isolates), sptB, typically lacked spacers 7 to 9 and 39, with 30% of
these strains also lacking between 1 and 16 additional spacers. The
smallest group, sptC, consisting of 15 isolates, typically lacked
spacer 34, with either spacers 29 to 33 or spacers 29 to 32 also
absent. In addition to the three baseline patterns described above,
many individual isolates further lacked one or more spacers, forming
clusters of strains with identical spoligotype patterns.
|
Correlation between IS6110 RFLP pattern and spoligotype. Although the fingerprints obtained by spoligotyping were less polymorphic than those obtained by probing with the IS6110 probe, there was an overall correlation between spoligotype and IS6110 RFLP pattern, even for strains with small numbers of IS6110 copies, confirming the genetic relatedness of the isolates identified by RFLP analysis.
All but five of the RFLP group A isolates exhibited the basic sptA spoligotype pattern (Table 2). Only one strain (strain IH-167), which fell into group A, had an sptB spoligotype pattern. This was a strain with a unique six-band IS6110 RFLP pattern and the only biovar 3 isolate that was sorted into group A on the basis of its RFLP pattern. All except four of the group B strains had the basic sptB spoligotype pattern, which lacked spacers 7 to 9 and 39. The four exceptional isolates possessed one or three spacers 7 to 9, while one of these isolates (isolate IH-133) additionally possessed spacer 39. The 15 group C isolates, which comprised the 12 isolates with one IS6110 copy, all had the same basic spoligotype pattern (pattern sptC).Correlation between IS6110 copy number and biovar. When the RFLP patterns of the individual isolates were compared to the results of the biochemical tests, a significant correlation was observed between IS6110 copy number and biovar classification (Fig. 2). Thus, the group of classical human M. tuberculosis isolates (biovar 5) had a significantly (P < 0.01 by the Wilcoxon rank sum test) larger number of IS6110 copies (mean copy number, 9; median copy number, 10), than the isolates that belonged to the intermediary biovars, biovars 2 to 4 (mean copy number, 5; median copy number, 5). The four M. bovis isolates carried three (one isolate), four (two isolates), and five (one isolate) copies of IS6110 (data not shown).
|
Correlation between IS6110 RFLP pattern and biovar. With a few exceptions, the biovar 5 isolates had the group A RFLP pattern and formed a distinct group. A total of 78 of the 85 biovar 5 isolates were in group A, while only 14 of the 51 biovar 4 isolates, 2 of the biovar 3 isolates, and none of biovar 1 and 2 isolates were in group A (Table 2). Additionally, many of the biovar 5 isolates in group A were highly related; 59 biovar 5 isolates belonged to two families of isolates with highly related banding patterns (similarity coefficient, >65%). In comparison to biovar 5, most of the isolates in biovars 1 to 4 had the main group B RFLP pattern.
Interestingly, however, isolates of the different biovars were more or less randomly distributed at the cluster level (similarity coefficient, >90%). Thus, isolates of the individual biovars did not segregate into specific individual RFLP clusters. For example, the largest cluster, cluster B:5 (32 isolates), with a typical four-band pattern, comprised isolates of all biovars, including one isolate of biovar 5 (Fig. 3). The isolates in group C, which comprised the isolates with two one-band clusters, were of biovars 3, 4, and 5 (Table 2).
|
M. bovis isolates. The four strains that were biochemically classified as M. bovis all belonged to group B. They had between three and five IS6110 insertions, but intriguingly, none of the insertions was located on the 1.9-kb PvuII restriction fragment that is typical for most M. bovis and M. bovis BCG strains. Interestingly, one IS6110 insertion location was common to all four M. bovis isolates: the IS6110 sequence was located on a fragment identical in size to the single band of cluster C:1. Additionally, all M. bovis isolates possessed spacers 40 to 43, which, together with spacer 39, have been reported to be lacking in M. bovis strains (17).
Correlation between type of strain and patient characteristics. There was no correlation between age, sex, or positivity for HIV with any particular type of strain. Of the eight isolates from patients from neighboring countries, one biovar 2 isolate from a patient from The Gambia and one biovar 3 isolate from a patient from Guinea Conakry clustered with the group B isolates. The six other isolates were of biovar 5 and clustered with the group A isolates.
| |
DISCUSSION |
|---|
|
|
|---|
As in a previous study (16), we have found a high degree of biochemical heterogeneity within strains of the M. tuberculosis complex isolated from Guinea-Bissau. In order to characterize this heterogeneity further at a genetic level, we subtyped isolates by DNA fingerprinting using the insertion element IS6110 and spoligotyping. Using these techniques, we were able to classify M. tuberculosis complex isolates into three groups. Group A isolates contained large numbers of IS6110 elements and a basic spoligotype pattern typical of classical human M. tuberculosis strains. Group B mainly comprised the intermediate biovars and the classical M. bovis strains, which are recognizable by the presence of few IS6110 copies per genome and a distinctive spoligotype pattern. In contrast, group C comprised a few isolates that mainly possessed a single IS6110 element. These DNA fingerprint results conform with recent observations from a study of M. africanum strains from Sierra Leone and Uganda (12). This study demonstrated that strains which had biochemical traits resembling those of M. bovis (Africanum I type) had IS6110 fingerprints that exhibited fewer bands, resulting in large clusters of strains with identical banding patterns, whereas strains that were biochemically more closely related to M. tuberculosis (Africanum II subtype) had a large number of fragments, with many individual banding patterns being observed.
European strains of M. tuberculosis are usually described as classical, are distinguishable by a large number of copies of IS6110 elements, and frequently lack the spoligotyping spacers 33 to 36 (8, 17). Interestingly, isolates of group A from Guinea-Bissau resembled European M. tuberculosis isolates in terms of biochemical traits, RFLP patterns, and spoligotypes when they were compared with isolates in an international database of the IS6110 patterns of M. tuberculosis complex isolates and also with strains from South and Central America (28a). Guinea-Bissau is a small country whose population has a rather high degree of mobility within the country but little contact with the populations of neighboring African countries. Historically, it is a former colony of Portugal, which is a country with a high incidence of TB caused by the classical human M. tuberculosis type. Even today, contacts between the populations of Guinea-Bissau and Portugal are probably still more numerous than contacts between the populations of Guinea-Bissau and other African countries. We therefore speculate that the group A M. tuberculosis strains, to which the majority of the biovar 5 isolates (i.e., the classical human variants) belonged, may have their origin within Europe, in particular, Portugal. Indeed, some of the isolates of group A had RFLP patterns that were identical to those of isolates from TB patients in Portugal (22).
Isolates of group B had few copies of IS6110 (mean copy number, 5) and highly conserved RFLP patterns as well as a homogeneous basic spoligotype pattern, which typically lacked spacers 7 to 9 and 39. This spoligotype pattern forms a baseline for all group B isolates. These common features indicate that the group B isolates are highly related to each other. Despite the genotypic similarities among these strains, the group B isolates showed a high degree of variability in terms of biochemical traits. Most of the larger clusters (on the basis of the IS6110 patterns) within group B contained isolates of different biovars. For example, the largest cluster (cluster B:5) of 32 isolates, presenting a typical four-band pattern, comprised isolates of all biovars, even including one isolate of biovar 5. Thus, despite the genetic stability in terms of the IS6110 fingerprints and the DR locus, the isolates varied in several phenotypic traits, which therefore could be used to further subdivide the different clusters determined by the DNA fingerprinting methods. One could speculate that the diversity in biochemical traits among these isolates reflects the ongoing evolution of M. tuberculosis complex in Guinea-Bissau or West Africa from classical M. bovis-like variants to more classical M. tuberculosis variants. This would mean, however, that the evolution of these properties is more rapid than the genetic evolution of IS6110 and the DR locus. Alternatively, the strains of biovars 1 to 4 may more readily switch on and off genes for, for example, niacin production during the adaptation to hosts of several species (and hence broaden their host tropism). Since only certain combinations of biochemical traits were found, such on-off switches for genes do not appear to occur randomly but, rather, occur as a stepwise turning on and off of genes in a defined sequence. For example, 69 isolates were positive for the production of niacin and negative for the production of nitrate reductase, but no isolate produced nitrate reductase but did not produce niacin. Recently, the pyrazinamidase gene (pncA) was cloned and a single point mutation in the gene was found to be unique to M. bovis (24). We sequenced the pncA genes of five cluster B:5 isolates, each representing one the five different biovars. Interestingly, none of them contained the M. bovis-specific mutation (data not shown).
Virtually all group B isolates contained spacers 33 to 36. These spacers were derived from the sequence of the BCG genome (17), supporting the relatedness of the group B isolates to M. bovis. It is generally supposed that M. bovis strains are more virulent for cattle, while classical M. tuberculosis strains are thought to be more virulent for humans. In Guinea-Bissau there is a high incidence of tuberculosis among cattle and goats. So far we have analyzed only one strain from a goat, with this isolate being of biovar 4 and showing an RFLP pattern and spoligotype identical to those of the four human biovar 4 isolates.
The four isolates in this study that were phenotypically characterized as M. bovis clustered with the group B isolates in terms of IS6110 RFLP and spoligotype patterns. Hence, they all had three to five copies of the IS6110 fragment, they all lacked the spacers 7 to 9 and 39, and they all contained spacers 33 to 36. M. bovis strains typically have small numbers of copies of the IS6110 insertion sequence (31, 32), while human and cattle M. bovis isolates in general harbor only a single copy of IS6110 (3, 11, 28), and it is usually located in the same position in the genome, on a characteristic 1.9-kb PvuII restriction fragment. In a report on the IS6110 RFLP patterns of 24 human M. bovis strains from The Netherlands, all strains had less than six copies, and one-third of the strains had only a single copy (31). By contrast, isolates from other animals appear to carry more IS6110 copies. In a study by van Soolingen et al. (30), the majority of isolates from cattle harbored a single IS6110 element, whereas the vast majority (29 of 34) of M. bovis isolates from a wide variety of other animals contained multiple IS6110 elements. During a study of Swedish M. bovis isolates from deer, we found that all isolates contained seven copies of the IS6110 element, yielding a highly specific RFLP pattern (28). Additionally, a study from Spain (11) demonstrated that M. bovis strains isolated from 23 goats carried six to eight copies of IS6110, while most isolates from cattle carried only a single copy of this element. Interestingly, the four M. bovis isolates in this study all had the sptB spoligotype pattern typical of the group B strains, which means that they all possessed spacers 40 to 43, which together with spacer 39 are reported to be lacking in all M. bovis and M. bovis BCG strains (17).
Cave and coworkers (1) suggested that the IS6110 insertion sequence originally appeared as a single copy in a progenitor of the M. tuberculosis complex and was retained as a single copy in M. bovis and then replicated to produce the multiple copies present in M. tuberculosis. They also suggested that these multiple insertional events may account for some of the phenotypic differences between M. tuberculosis and M. bovis. Our finding of a correlation between the phenotypic variants of strains of the M. tuberculosis complex and the number of IS6110 insertion elements supports such a hypothesis. Fomukong and coworkers (7) analyzed selected M. tuberculosis complex strains from Malaysia, Tanzania, and Oman as well as M. bovis isolates and M. bovis BCG strains, all of which carried a single copy of the insertion sequence, and suggested that in these organisms the IS6110 element is defective in transposition and that the loss of transposability may have occurred at an early stage in the evolution of the M. tuberculosis complex. The progenitor would therefore have had a single copy of the insertion sequence; the multicopy M. tuberculosis strains would therefore have evolved by replicative transposition of the element. It may be speculated that the small number of copies of the IS6110 fragment in the group B and C strains in this study reflects a similar defect in transposition of IS6110. Hermans and coworkers (14), however, found that the insertion sequence sequence element of M. bovis BCG was not defective in transposition but, rather, that it was located in a hot-spot integration region in the DR locus.
It has been reported earlier that M. tuberculosis strains isolated from patients in countries with a high prevalence of TB exhibit less DNA polymorphism than strains from patients in countries that have a low prevalence of TB, such as The Netherlands (31). In countries with a high prevalence of TB, such as Ethiopia and Tunisia, the majority of circulating M. tuberculosis strains belong to a limited number of strain families (13) and supposedly descend from a few clones that expanded in the recent past. In the present study there was a high proportion of clustering of the isolates by IS6110 RFLP patterns, resulting in a limited number of different RFLP banding patterns. This clustering was highest in group B, with clusters significantly larger than those in group A. On the basis of the large size of the major group B clusters, it appears that these strains have some selective advantage in this geographical area. In this study two of the eight isolates from patients from neighboring countries clustered with group B isolates; one was a biovar 2 isolate from a patient from The Gambia and one was a biovar 3 isolate from a patient from Guinea Conakry.
From an evolutionary point of view, we suggest that the group B and C isolates, including the four M. bovis isolates, belong to a unique branch of the M. tuberculosis tree, with their origin in West African countries. We suggest that these genetically similar strains have a recent common ancestral "M. bovis-like" origin and that they are better adapted for infection and survival in the range of hosts present in this geographical area. This genotype may have a short history of adaptation to humans, since TB in sub-Saharan Africa has been suggested to be a recently occurring disease, in contrast to TB in northern Europe and the Americas (26). We also propose that the M. bovis strains of the "European" type (which possess a single IS6110 fragment and which lack DR spacer sequences 39 to 43) branched off at an earlier stage than the M. bovis strains of the type found in this study.
| |
ACKNOWLEDGMENTS |
|---|
We thank H. Heersma for helpful advice and J. van Embden and Dan Anderson for fruitful discussions.
The study was supported by the Swedish Medical Research Council (project no. 13027); the Agency for Research Cooperation with Developing Countries; the Swedish Heart-Lung Foundation; the Commission of the European Communities, Directorate General XII, Biomedical and Health Research, Biomed 1 (contract BMH1-CT93-1614); and the World Health Organization Programme for Vaccine Development.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Swedish Institute for Infectious Disease Control, S-17182 Solna, Sweden. Phone: 46 8 4572430. Fax: 46 8 301797. E-mail: gunilla.kallenius{at}smi.ki.se.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Cave, M. D., K. D. Eisenach, P. F. McDermott, J. H. Bates, and J. T. Crawford. 1991. IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol. Cell. Probes 5:73-80[Medline]. |
| 2. | Collins, C. H., M. D. Yates, and J. M. Grange. 1982. Subdivision of Mycobacterium tuberculosis into five variants for epidemiological purposes: methods and nomenclature. J. Hyg. Camb. 89:235-242. |
| 3. |
Collins, D. M.,
S. Erasmuson,
D. M. Stephens,
G. F. Yates, and G. W. De Lisle.
1993.
DNA fingerprinting of Mycobacterium bovis strains by restriction fragment analysis and hybridization with insertion elements IS1081 and IS6110.
J. Clin. Microbiol.
31:1143-1147 |
| 4. | David, H. L., M. T. Jahan, A. Jumin, J. Grandry, and E. H. Lehman. 1978. Numerical taxonomy analysis of Mycobacterium africanum. Int. J. Syst. Bacteriol. 28:467-472. |
| 5. | Dias, F., S. Ghebremichael, S. E. Hoffner, L. Martins, R. Norberg, and G. Källenius. 1993. Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tubercle 74:129-130. |
| 6. | Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull W. H. O. 72:213-220[Medline]. |
| 7. | Fomukong, N. G., J. W. Dale, T. W. Osborn, and J. M. Grange. 1992. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J. Appl. Bacteriol. 72:126-133[Medline]. |
| 8. | Goguet de la Salmoniere, Y.-O., H. Minh Li, G. Torrea, A. Buschoten, A. J. van Embden, and B. Gicquel. 1997. Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J. Clin. Microbiol. 35:2210-2214[Abstract]. |
| 9. | Groenen, P. M. A., A. E. Bunschoten, D. van Soolingen, and J. D. A. van Embden. 1991. Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel method. Mol. Microbiol. 105:1057-1065. |
| 10. | Groothuis, D. G., and M. D. Yates (ed.). 1991. Manual of diagnostic and public health mycobacteriology, 2nd ed. Bureau of Hygiene and Tropical Diseases, European Society for Mycobacteriology, London, United Kingdom. |
| 11. | Gutierrez, M., S. Samper, J.-A. Gavigan, J. F. G. Marin, and C. Martin. 1995. Differentiation by molecular typing of Mycobacterium bovis strains causing tuberculosis in cattle and goats. J. Clin. Microbiol. 33:2953-2956[Abstract]. |
| 12. | Haas, W. H., G. Bretzel, B. Amthor, K. Schilke, G. Krommes, S. Rusch-Gerdes, V. Sticht-Groh, and H. J. Bremer. 1997. Comparison of DNA fingerprint patterns of isolates of Mycobacterium africanum from East and West Africa. J. Clin. Microbiol. 35:663-666[Abstract]. |
| 13. | Hermans, P. W. M., F. Messadi, H. Guebrexabher, D. van Soolingen, P. E. W. de Haas, H. Heersma, H. de Neeling, A. Ayoub, F. Portaels, D. Frommel, M. Zribi, and J. van Embden. 1995. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J. Infect. Dis. 171:1504-1513[Medline]. |
| 14. |
Hermans, P. W. M.,
D. van Soolingen,
E.-M. Bik,
P. E. W. de Haas,
J. W. Dale, and J. D. A. van Embden.
1991.
The insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains.
Infect. Immun.
59:2695-2705 |
| 15. | Hoffner, S. E., and G. Källenius. 1998. Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin. Eur. J. Clin. Microbiol. Infect. Dis. 7:188-190. |
| 16. |
Hoffner, S. E.,
S. B. Svenson,
R. Norberg,
F. Dias,
S. Ghebremichael, and G. Källenius.
1993.
Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau.
J. Clin. Microbiol.
31:2215-2217 |
| 17. | Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. Van Soolingen, S. Kuijper, A. Bunschoten, H. Molbuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914[Abstract]. |
| 18. | Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology. A guide for the level III laboratory. Centers for Disease Control, Atlanta, Ga. |
| 19. | Koivula, T., S. Hoffner, N. Winqvist, A. Nauciér, F. Dias, S. Svenson, R. Norberg, and G. Källenius. 1996. Mycobacterium avium complex sputum isolates from patients with respiratory symptoms in Guinea Bissau. J. Infect. Dis. 173:263-265[Medline]. |
| 20. | Murray, C. J. L., K. Styblo, and A. Rouillon. 1990. Tuberculosis in the developing countries: burden, intervention and cost. Tuber. Lung Dis. 65:6-24. |
| 21. | Naucler, A., N. Winquist, F. Dias, T. Koivula, L. De Lacerda, S. B. Svenson, G. Biberfeld, R. Norberg, and G. Källenius. 1996. Pulmonary tuberculosis in Guinea Bissau. Clinical and bacteriological findings, HIV-status and short term survival of hospitalized patients. Tuber. Lung Dis. 77:197-292[Medline]. |
| 22. | Portugal, G., L. Brum, M. Viveiros, J. Moniz Pereira, and H. David. 1998. Tipificacao genetica de estirpes multiresistentes de Mycobacterium tuberculosis isoladas na regiao de Lisboa. Rev. Port. Doencas Infect. 21:54-59. |
| 23. | Prat, R., N. Rist, N. Dumitrescu, A. Mugabushaka, S. Clavel, and C. Duponchel. 1974. Special characteristics of the cultures of tubercle bacilli isolated in Ruanda. Bull. Int. Union Tuber. 49:53-62. |
| 24. | Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667[Medline]. |
| 25. | Snider, D. E., R. C. Good, J. O. Kilburn, L. F. Laskowski, Jr., R. H. Lusk, J. J. Marr, Z. Reggiardo, and G. Middlebrook. 1981. Rapid drug-susceptibility testing of M. tuberculosis. Am. Rev. Respir. Dis. 123:402-406[Medline]. |
| 26. | Stead, W. W. 1997. The origin and erratic global spread of tuberculosis. Clin. Chest Med. 18:65-77[Medline]. |
| 27. | Sudre, P., H. G. ten Dam, and A. Kochi. 1992. Tuberculosis: a global overview of the situation today. Bull. W. H. O. 70:149-159[Medline]. |
| 28. | Szewzyk, R., S. E. Hoffner, G. Bölske, S. B. Svenson, and G. Källenius. 1995. Molecular epidemiological studies of Mycobacterium bovis infections in humans and animals in Sweden. J. Clin. Microbiol. 33:3183-3185[Abstract]. |
| 28a. | van Embden, J. Personal communication. |
| 29. |
van Embden, J.,
M. D. Cave,
J. T. Crawford,
J. W. Dale,
K. D. Eisenach,
B. Gicquel,
P. Hermans,
C. Martin,
R. McAdam,
T. M. Shinnik, and P. M. Small.
1993.
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.
J. Clin. Microbiol.
31:406-409 |
| 30. |
van Soolingen, D.,
P. E. W. de Haas,
J. Haagsma,
T. Eger,
P. W. Hermans,
V. Ritacco,
A. Alito, and J. D. van Embden.
1994.
Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis.
J. Clin. Microbiol.
32:2425-2433 |
| 31. |
van Soolingen, D.,
P. W. M. Hermans,
P. E. W. de Haas,
D. R. Soli, and J. D. A. van Embden.
1991.
Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis.
J. Clin. Microbiol.
29:2578-2586 |
| 32. |
van Soolingen, D.,
P. W. M. Hermans,
P. E. W. de Haas, and J. D. A. van Embden.
1992.
Insertion element IS1081-associated restriction fragment length polymorphism in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG.
J. Clin. Microbiol.
30:1772-1777 |
| 33. | Wayne, L. G. 1985. The "atypical" mycobacteria: recognition and disease association. Crit. Rev. Microbiol. 12:185-222[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»